-
1. Effectiveness of Favipiravir monotherapy in the treatment of C…
Link: https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(23)00026-4/fulltext
Description: The current evidence indicates that favipiravir is effective in COVID-19, both moderate to severe and severe pulmonary involvement. The benefit of early treatment with Favipiravir monotherapy is reduced mortality risk, especially in elderly (>65 years), hypertension, and obesity patients. api
api
-
2. NSTDA and GPO set to scale up favipiravir API manufacturing proc…
Link: https://www.nstda.or.th/en/news/news-years-2021/nstda-and-gpo-set-to-scale-up-favipiravir-api-manufacturing-process.html
Description: Mar 5, 2021 · Favipiravir is an antiviral drug reportedly effective against the SARS-CoV-2, the virus that causes COVID-19. API or …
-
3. An economical and practical procedure of favipiravir synthesis …
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685009/
Description: Nov 21, 2022 · Keywords: Favipiravir synthesis, 3,6-Dichloropyrazine-2-carbonitrile, Covid-19 treatment, Process development, Active … DOI: 10.1007/s11696-022-02595-1 Publication: Chem Zvesti. 2023; 77(3): 1695-1702. Published: 2023
DOI: 10.1007/s11696-022-02595-1Publication: Chem Zvesti. 2023; 77(3): 1695-1702.Published: 2023
-
4. Favipiravir and Its Structural Analogs: Antiviral Activity and
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307979/
Description: Dec 8, 2021 · We provide data on the synthesis and antiviral activity of structural analogs of favipiravir, including nucleosides and … DOI: 10.32607/actanaturae.11652 Publication: Acta Naturae. 2022 Apr-Jun; 14(2): 16-38. Published: Apr-Jun 2022 api
DOI: 10.32607/actanaturae.11652Publication: Acta Naturae. 2022 Apr-Jun; 14(2): 16-38.Published: Apr-Jun 2022api
-
5. Role of favipiravir in the treatment of COVID-19 - PMC
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831863/
Description: Oct 30, 2020 · Favipiravir (prodrug) is a purine base analog that is converted to active … Author: Shashank Joshi, Jalil Parkar, Abdul Ansari, Agam Vora, Deepak Talwar, Mangesh Tiwaskar, Saiprasad Pa... Publish Year: 2021 DOI: 10.1016/j.ijid.2020.10.069 Publication: Int J Infect Dis. 2021 Jan; 102: 501-508. api
Author: Shashank Joshi, Jalil Parkar, Abdul Ansari, Agam Vora, Deepak Talwar, Mangesh Tiwaskar, Saiprasad Pa...Publish Year: 2021DOI: 10.1016/j.ijid.2020.10.069Publication: Int J Infect Dis. 2021 Jan; 102: 501-508.api
-
6. Avra Laboratories gets CDSCO nod to make Favipiravir API
Link: https://health.economictimes.indiatimes.com/news/pharma/avra-laboratories-gets-cdsco-nod-to-make-favipiravir-api/77217410
Description: Jul 28, 2020 · Hyderabad: Avra Laboratories Pvt Ltd ,a city based pharma company, has been granted regulatory approval by the Central Drugs Standard Control …
-
7. The efficacy and safety of Favipiravir in treatment of COVID-…
Link: https://www.nature.com/articles/s41598-021-90551-6
Description: May 26, 2021 · Article. Open access. Published: 26 May 2021. The efficacy and safety of Favipiravir in treatment of COVID …
-
8. Biophore gets DCGI nod to make, export Favipiravir API - The Hindu
Link: https://www.thehindu.com/sci-tech/health/biophore-india-gets-dcgi-nod-to-manufacture-covid-19-drug-favipiravir/article32076479.ece
Description: Jul 14, 2020 · Biophore India Pharmaceuticals has received Drugs Controller General of India licence to manufacture and export …